HERC5, a HECT E3 ubiquitin ligase tightly regulated in LPS activated endothelial cells

Journal of Cell Science

Volumn 117, Issue 20, 2004, Pages 4749-4756

  Kroismayr, Renate ^a   Baranyi, Ulrike ^a,b   Stehlik, Christian ^a,c   Dorfleutner, Andrea ^a,c   Binder, Bernd R ^a   Lipp, Joachim ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Inflammation; LPS; NF ; Ubiquitin ligase

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; HECT AND RCC1 DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIGASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; REGULATOR OF CHROMOSOME CONDENSATION 1 PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE HERC5; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL WALL; CELL ACTIVATION; CONTROLLED STUDY; CYTOSOL; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME REGULATION; FIBROBLAST; GENE EXPRESSION REGULATION; GENE ISOLATION; GENETIC CODE; GENETIC SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MICROVASCULATURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SKIN BLOOD VESSEL; SMOOTH MUSCLE FIBER; UPREGULATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SEQUENCE ALIGNMENT; SKIN; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 7244261878     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01338     Document Type: Article

References (54)

1. Akira, S., Takeda, K. and Kaisho, T. (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680.
2. Aravind, L. and Koonin, E. V. (2000). The U box is a modified RING finger - a common domain in ubiquitination. Curr. Biol. 10, R132-R134.
3. Baarends, W. M., van der Laan, R. and Grootegoed, J. A. (2000). Specific aspects of the ubiquitin system in spermatogenesis. J. Endocrinol. Invest. 23, 597-604.
4. Bierhaus, A., Chen, J., Liliensiek, B. and Nawroth, P. P. (2000). LPS and cytokine-activated endothelium. Semin. Thromb. Hemost. 26, 571-587.
5. Brostjan, C., Anrather, J., Csizmadia, V., Natarajan, G. and Winkler, H. (1997). Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. J. Immunol. 158, 3836-3844.
6. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G. and Siebenlist, U. (1995). Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488.
7. Chen, Z., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard, D. and Maniatis, T. (1995). Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9, 1586-1597.
8. Coussens, L. M. and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867.
9. Cruz, C., Ventura, F., Bartrons, R. and Rosa, J. L. (2001). HERC3 binding to and regulation by ubiquitin. FEBS Lett. 488, 74-80.
10. De Martin, R., Raidl, M., Hofer, E. and Binder, B. R. (1997). Adenovirus-mediated expression of green fluorescent protein. Gene Ther. 4, 493-495.
11. De Martin, R., Hoeth, M., Hofer-Warbinek, R. and Schmid, J. A. (2000). The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler. Thromb. Vasc. Biol. 20 E83-E88.
12. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C. and Chen, Z. J. (2000). Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361.
13. Fontijn, R., Hop, C., Brinkman, H. J., Slater, R., Westerveld, A., van Mourik, J. A. and Pannekoek, H. (1995). Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirrus containing human papilloma virus 16 E6/E7 DNA. Exp. Cell Res. 216, 199-207.
14. Ghosh, S. and Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109, S81-S96.
15. Ghosh, S., May, M. J. and Kopp, E. B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
16. Hershko, A., Ciechanover, A. and Varshavsky, A. (2000). Basic Medical Research Award. The ubiquitin system. Nat. Med. 6 1073-1081.
17. Hicke, L. (2001). Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2, 195-201.
18. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. and Pease, L. R. (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.
19. Hofer-Warbinek, R., Schmid, J. A., Stehlik, C., Binder, B. R., Lipp, J. and de Martin, R. (2000). Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275, 22064-22068.
20. Huibregtse, J. M., Scheffner, M., Beaudenon, S. and Howley, P. M. (1995). A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92, 5249.
21. Jensen, J. P., Bates, P. W., Yang, M., Vierstra, R. D. and Weissman, A. M. (1995). Identification of a family of closely related human ubiquitin conjugating enzymes. J. Biol. Chem. 270, 30408-30414.
22. Kadl, A., Huber, J., Gruber, F., Bochkov, V. N., Binder, B. R. and Leitinger, N. (2002). Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS. Vascul. Pharmacol. 38 219-227.
23. Kaiser, P., Mandl, S., Schweiger, M. and Schneider, R. (1995). Characterization of functionally independent domains in the human ubiquitin conjugating enzyme UbcH2. FEBS Lett. 377, 193-196.
24. Kracht, M. and Saklatvala, J. (2002). Transcriptional and posttranscriptional control of gene expression in inflammation. Cytokine 20, 91-106.
25. Kumar, S., Kao, W. H. and Howley, P, M. (1997). Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity. J. Biol. Chem. 272, 13548-13554.
26. Lehman, A. L., Nakatsu, Y., Ching, A., Bronson, R. T., Oakey, R. J., Keiper-Hrynko, N., Finger, J. N., Durham-Pierre, D., Horton, D. B., Newton, J. M. et al. (1998). A very large protein with diverse functional motifs is deficient in rjs (runty, jerky, sterile) mice. Proc. Natl. Acad. Sci. USA 95, 9436-9441.
27. Li, Q. and Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
28. Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S. and Weissman, A. M. (1999). RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96, 11364-11369.
29. Majetschak, M., Suciu, D. M., Hasler, K., Obertacke, U., Schade, F. U. and Jennissen, H. P. (2000). Cytosolic protein ubiquitylation in normal and endotoxin stimulated human peripheral blood mononuclear cells. J. Endotoxin Res. 6, 483-488.
30. Mitsui, K., Nakanishi, M., Ohtsuka, S., Norwood, T. H., Okabayashi, K., Miyamoto, C., Tanaka, K., Yoshimura, A. and Ohtsubo, M. (1999). A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins. Biochem. Biophys. Res. Commun. 266, 115-122.
31. Nathan, C. (2002). Points of control in inflammation. Nature 420, 846-852.
32. Nuber, U., Schwarz, S., Kaiser, P., Schneider, R. and Scheffner, M. (1996). Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction with E6-AP and RSP5. J. Biol. Chem. 271, 2795-2800.
33. Ohta, T., Michel, J. J., Schottelius, A. J. and Xiong, Y. (1999). ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell 3, 535-541.
34. Pickart, C. M. (2001). Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533.
35. Plon, S. E., Leppig, K. A., Do, H. N. and Groudine, M. (1993). Cloning of the human homolog of the CDC34 cell cycle gene by complementation in yeast. Proc. Natl. Acad. Sci. USA 90, 10484-10488.
36. Rosa, J. L. and Barbacid, M. (1997). A giant protein that stimulates guanine nucleotide exchange on ARF1 and Rab proteins forms a cytosolic ternary complex with clathrin and Hsp70. Oncogene 15, 1-6.
37. Rosa, J. L., Casaroli-Marano, R. P., Buckler, A. J., Vilaro, S. and Barbacid, M. (1996). p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins. EMBO J. 15, 4262-4273.
38. Scheffner, M., Huibregtse, J. M., Vierstra, R. D. and Howley, P. M. (1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 495-505.
39. Scheffner, M., Huibregtse, J. M. and Howley, P. M. (1994). Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. USA 91, 8797-8801.
40. Schwarz, S. E., Rosa, J. L. and Scheffner, M. (1998). Characterization of human hect domain family members and their interaction with UbcH5 and UbcH7. J. Biol. Chem. 273, 12148-12154.
41. Stehlik, C., de Martin, R., Binder, B. R. and Lipp, J. (1998a). Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B. Biochem. Biophys. Res. Commun. 243, 827-832.
42. Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, J. A., Binder, B. R. and Lipp, J. (1998b). Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188, 211-216.
43. Suzuki, Y., Nakabayashi, Y. and Takahashi, R. (2001). Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. USA 98, 8662-8667.
44. Thrower, J. S., Hoffman, L., Rechsteiner, M. and Pickart, C. M. (2000). Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102.
45. Townsley, F. M., Aristarkhov, A., Beck, S., Hershko, A. and Ruderman, J. V. (1997). Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc. Natl. Acad. Sci. USA 94, 2362-2367.
46. Weissman, A. M. (2001). Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2, 169-178.
47. Wojta, J., Zoellner, H., Gallicchio, M., Hamilton, J. A. and McGrath, K. (1992). Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem. Biophys. Res. Commun. 188, 463-469.
48. Wojta, J., Gallicchio, M., Zoellner, H., Hufnagl, P., Last, K., Filonzi, E. L., Binder, B. R., Hamilton, J. A. and McGrath, K. (1993). Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb. Haemost. 70, 469-474.
49. Wong, E. Y., Tse, J. Y., Yao, K. M., Tam, P. C. and Yeung, W. S. (2002). VCY2 protein interacts with the HECT domain of ubiquitin-protein ligase E3A. Biochem. Biophys. Res. Commun. 296 1104-1111.
50. Wrighton, C. J., Hofer-Warbinek, R., Moll, T., Eytner, R., Bach, F. H. and de Martin, R. (1996). Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J. Exp. Med. 183, 1013-1022.
51. Yamamoto, Y. and Gaynor, R. B. (2001). Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 1, 287-296.
52. Yang Y., Fang, S., Jensen, J. P., Weissman, A. M. and Ashwell, J. D. (2000). Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877.
53. Zhang, J. C., Fabry, A., Paucz, L., Wojta, J. and Binder, B. R. (1996). Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells. Blood 88, 3880-3886.
54. Zhang, G. and Ghosh, S. (2000). Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J. Endotoxin Res. 6, 453-457.